Prolonged treatment of neuroendocrine carcinoma of the cervix with a PARP inhibitor based on next generation sequencing
Saved in:
Main Author: | Peter G. Rose (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Response to MEK inhibitor in small cell neuroendocrine carcinoma of the cervix with a KRAS mutation
by: Yasmin A. Lyons, et al.
Published: (2014) -
Incorporation of immunotherapy into the treatment of metastatic neuroendocrine carcinoma of the cervix: A case report
by: Akanksha Suresh, et al.
Published: (2023) -
Next Generation Sequencing Advances, Applications and Challenges
Published: (2016) -
Large Cell Neuroendocrine Carcinoma of the Uterine Cervix Associated with Adenocarcinoma
by: Ma-Lee Ko, et al.
Published: (2007) -
Next-Generation Sequencing in Pharmacogenetics/genomics
Published: (2020)